Total raised
$1.0M
Last: Pre-Seed 2022-01
Stage
Pre-Seed
Founded
2021
Headcount
6
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences
About
SLATE Therapeutics is dedicated to revolutionizing the treatment of chronic rhinosinusitis (CRS) with SilexGel, a novel sol-gel hydrogel technology.
Its mission is to improve patients' quality of life through innovative and effective treatments. SilexGel is a cutting-edge platform technology designed for the systemic and localized delivery of therapeutics. Unlike drug-eluting implants that tend to migrate and cause side effects, or nasal sprays that offer short-term relief, SilexGel provides long-lasting effects with minimal side effects.
Funding history · 1 round · $1.0M total
2022-01
Pre-Seed
$1.0M
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Slate Therapeutics' primary focus?
- Slate Therapeutics is dedicated to revolutionizing the treatment of chronic rhinosinusitis (CRS) using SilexGel, a novel sol-gel hydrogel technology.
- When was Slate Therapeutics founded?
- Slate Therapeutics was founded in April 2021.
- What is SilexGel and its purpose?
- SilexGel is a cutting-edge platform technology developed by Slate Therapeutics for the systemic and localized delivery of therapeutics, designed to provide long-lasting effects with minimal side effects for CRS patients.
- How much funding has Slate Therapeutics raised in total?
- Slate Therapeutics has raised a total of $1,000,000 USD.
- What was Slate Therapeutics' most recent funding round?
- Slate Therapeutics completed a Pre-Seed funding round in January 2022, raising $1,000,000 USD.
- Which investors participated in Slate Therapeutics' Pre-Seed round?
- The Pre-Seed round for Slate Therapeutics in January 2022 was led by NGT HealthCare II, with participation from the Israel Innovation Authority.
- Where is Slate Therapeutics headquartered?
- Slate Therapeutics is headquartered in Tel Aviv-Yafo, Israel.
- How many employees does Slate Therapeutics currently have?
- Slate Therapeutics has 6 employees.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryDrugs Discovery & Development
Target customers
Healthcare & Life SciencesMedical Devices IndustryMedical ProductsHealthcarePatients
Business model
B2B2C
Highlights
Verified
Tags
drug-deliveryhealthcaremedical-devicestreatmentsoral-drugs